AI Diagnostics

Twitter

Facebook

Copy Link

Key Facts

Key AreasRadiology, Pathology, Retinal Scans

Key PlayersPathAI, Viz.ai, Google Health

Top News

Michael and Susan Dell pledge $750 million to build country's first AI-native hospital at UT Austin

Dell Technologies founder Michael Dell and his wife Susan are donating $750 million to the University of Texas at Austin to build the country's first AI-native hospital. The UT Dell Medical Center will open in 2030 on a 300-acre research campus, integrating artificial intelligence into patient care from the ground up. The donation pushes the couple's total giving to UT Austin past $1 billion.

Health3 sources

Michael and Susan Dell pledge $750 million to build country's first AI-native hospital at UT Austin

Health3 sources

Multimodal AI model predicts PIK3CA mutations in breast cancer with cost-effective precision

Researchers from Hebei Medical University Fourth Hospital developed a multimodal AI framework that combines whole-slide pathology images with clinical data to predict PIK3CA mutations in breast cancer. The model achieved an AUC of 0.745 in internal testing and demonstrated strong generalizability across external cohorts, offering a practical alternative to expensive molecular testing for guiding PI3K-targeted therapies.

Science2 sources

Multimodal AI model predicts PIK3CA mutations in breast cancer with cost-effective precision

Science2 sources

AI digital twin reveals loneliness and insomnia dramatically increase diabetes risk

A groundbreaking AI-based digital twin model from Anglia Ruskin University analyzed 17 years of data from nearly 20,000 UK adults and found that loneliness, insomnia, and poor mental health each raise type 2 diabetes risk by 35 percentage points. When combined, these psychological factors increase risk by 78 percentage points, highlighting how chronic stress responses affect metabolic health in ways traditional prediction models miss.

Health2 sources

AI digital twin reveals loneliness and insomnia dramatically increase diabetes risk

Health2 sources

Oxford AI tool predicts heart failure risk five years early by detecting invisible heart fat

Scientists at the University of Oxford developed an AI tool that predicts heart failure risk up to 5 years in advance with 86% accuracy. The technology analyzes routine cardiac CT scans to detect subtle changes in fat around the heart linked to inflammation—changes invisible to clinicians using standard imaging techniques. High-risk patients were 20 times more likely to develop heart failure than those at lowest risk.

Health2 sources

Oxford AI tool predicts heart failure risk five years early by detecting invisible heart fat

Health2 sources

AI learns to identify childhood cancer survivors who need extra support through patient conversations

Artificial intelligence could help physicians determine which childhood cancer survivors need additional support by analyzing patient conversations. Researchers at St. Jude Children's Research Hospital found that large language models using complex prompting strategies can detect symptom severity in interviews with survivors and caregivers, potentially transforming how physicians use conversational data to improve survivorship care.

Health2 sources

AI learns to identify childhood cancer survivors who need extra support through patient conversations

Health2 sources

Adversarial AI uncovers hidden brain mechanisms and potential treatments for disorders of consciousness

Researchers at UCLA developed a generative adversarial artificial intelligence framework that pits two AI models against each other to simulate conscious and unconscious brain states. The system, trained on over 680,000 neuroelectrophysiology samples, identified previously unknown mechanisms behind coma and predicted that stimulation of the subthalamic nucleus could help restore consciousness in patients with brain injuries.

Science2 sources

Adversarial AI uncovers hidden brain mechanisms and potential treatments for disorders of consciousness

Science2 sources

Firefly Neuroscience stock surges 47.7% on AI-powered ADHD subtype diagnosis breakthrough

Firefly Neuroscience shares soared 47.7% to $2.57 on Friday after the company announced research advances using AI-powered EEG technology to distinguish between ADHD subtypes. The breakthrough targets a U.S. treatment market estimated at over $10 billion and could shift diagnosis from symptom-based assessments to objective neural biomarkers.

Health2 sources

Firefly Neuroscience stock surges 47.7% on AI-powered ADHD subtype diagnosis breakthrough

Health2 sources

AI boosts breast cancer detection by 10% in major UK screening studies, flags hidden cancers

Major UK studies show AI integration into breast cancer screening increases detection rates by 10.4% and identifies up to 27.5% of interval cancers before they become visible. The technology also reduces radiologist workload by up to 44% while maintaining accuracy across diverse populations, marking a shift in how screening programs could operate.

Health6 sources

AI boosts breast cancer detection by 10% in major UK screening studies, flags hidden cancers

Health6 sources

AI chatbots miss most medical diagnoses as millions seek health advice from ChatGPT

More than 40 million people consult ChatGPT daily for health information, but new research reveals AI chatbots correctly identify medical conditions only 34.5% of the time. Studies show these tools undertriage 52% of emergency cases and provide correct follow-up steps just 44.2% of the time, raising urgent questions about patient safety as AI healthcare becomes mainstream.

Health7 sources

AI chatbots miss most medical diagnoses as millions seek health advice from ChatGPT

Health7 sources

Eight Sleep raises $50M at $1.5B valuation to build predictive AI agent for sleep optimization

Sleep technology company Eight Sleep secured $50 million in strategic funding led by Tether Investments, reaching a $1.5 billion valuation. The company plans to develop a sleep-focused AI agent trained on over 1 billion hours of sleep data while advancing FDA filings for sleep apnea detection and expanding globally across 34 countries.

Startups2 sources

Eight Sleep raises $50M at $1.5B valuation to build predictive AI agent for sleep optimization

Startups2 sources

Droplet Biosciences slashes cancer test time from 10 days to 2 using NVIDIA AI infrastructure

Droplet Biosciences has partnered with NVIDIA to dramatically accelerate residual cancer detection after surgery. Using NVIDIA Parabricks GPU-accelerated software, the diagnostics startup reduced genomic analysis time from 10 days to just 2 days, with key steps like variant calling dropping from 36 hours to under 3 hours. The breakthrough enables clinicians to receive actionable insights while patients are still in the hospital.

Technology2 sources

Droplet Biosciences slashes cancer test time from 10 days to 2 using NVIDIA AI infrastructure

Technology2 sources

Ultrahuman Ring Pro debuts with 15-day battery life and Jade AI, but US launch remains uncertain

Ultrahuman unveiled its Ring Pro smart ring with industry-leading 15-day battery life and launched Jade AI, a biointelligence platform that synthesizes health data for real-time insights. The $479 device ships globally in March, but a patent dispute with Oura keeps it off US shelves for now. The company has submitted a redesigned version to US Customs for clearance.

Technology7 sources

Ultrahuman Ring Pro debuts with 15-day battery life and Jade AI, but US launch remains uncertain

Technology7 sources

AI model predicts bone removal in cochlear implant surgery to enhance surgical planning

Researchers from Vanderbilt University and partners developed an AI model that predicts bone removal during cochlear implant surgery. The system analyzes CT scans to forecast mastoidectomy shape, achieving a 0.72 Dice score across 751 cases. This medical imaging technology could support robotic surgical tools and improve patient outcomes.

Science2 sources

AI model predicts bone removal in cochlear implant surgery to enhance surgical planning

Science2 sources

Tempus AI stock rises 3.5% after unveiling HRD-RNA algorithm for cancer detection

Tempus AI shares climbed Wednesday following the launch of its new HRD-RNA algorithm, an AI-driven tool designed to detect homologous recombination deficiency in tumors. The algorithm analyzes gene expression to identify patients who may benefit from platinum-based chemotherapy or PARP inhibitors, offering a more dynamic assessment than traditional genomic methods.

Health2 sources

Tempus AI stock rises 3.5% after unveiling HRD-RNA algorithm for cancer detection

Health2 sources

India launches SAHI and BODH initiatives to advance safe AI in healthcare at AI Impact Summit

Union Health Minister JP Nadda unveiled two pioneering digital health initiatives—SAHI and BODH—at the India AI Impact Summit 2026 in New Delhi. The launch marks a significant step toward safe, ethical AI deployment in India's healthcare ecosystem. SAHI provides a governance framework for responsible AI use, while BODH offers a platform for testing and validating AI solutions before large-scale deployment.

Policy10 sources

India launches SAHI and BODH initiatives to advance safe AI in healthcare at AI Impact Summit

Policy10 sources

Prev 1 234 Next